» Articles » PMID: 32274750

A Map of Racial and Ethnic Disparities in Influenza Vaccine Uptake in the Medicare Fee-for-Service Program

Overview
Journal Adv Ther
Date 2020 Apr 11
PMID 32274750
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Despite improved understanding of the risks of influenza and better vaccines for older patients, influenza vaccination rates remain subpar, including in high-risk groups such as older adults, and demonstrate significant racial and ethnic disparities.

Methods: This study considers demographic, clinical, and geographic correlates of influenza vaccination among Medicare Fee-for-Service (FFS) beneficiaries in 2015-2016 and maps the data on a geographic information system (GIS) at the zip code level.

Results: Analyses confirm that only half of the senior beneficiaries evidenced a claim for receiving an inactivated influenza vaccine (IIV), with significant disparities observed among black, Hispanic, rural, and poorer beneficiaries. More extensive disparities were observed for the high-dose (HD) vaccine, with its added protection for older populations and confirmed economic benefit. Most white beneficiaries received HD; no non-white subgroup did so. Mapping of the data confirmed subpar vaccination in vulnerable populations with wide variations at the zip code level.

Conclusion: Urgent and targeted efforts are needed to equitably increase IIV rates, thus protecting the most vulnerable populations from the negative health impact of influenza as well as the tax-paying public from the Medicare costs from failing to do so.

Citing Articles

Building and Sustaining Flu Vaccine Acceptance and Trust in the Black Community through Partnerships with Churches, Salons, and Barbershops.

Nuss H, Privor-Dumm L, Ukachukwu C, Hall L J Racial Ethn Health Disparities. 2024; .

PMID: 39240452 DOI: 10.1007/s40615-024-02141-7.


Exploring the future adult vaccine landscape-crowded schedules and new dynamics.

Jones C, Jenkins M, Williams B, Welch V, True J NPJ Vaccines. 2024; 9(1):27.

PMID: 38336933 PMC: 10858163. DOI: 10.1038/s41541-024-00809-z.


Investigation of barriers to county-level seasonal influenza vaccine uptake among Medicare beneficiaries in the United States - 2018-2019 seasonal influenza season.

Cho B, OHalloran A, Pike J Vaccine X. 2023; 14:100326.

PMID: 37577260 PMC: 10422654. DOI: 10.1016/j.jvacx.2023.100326.


Geographic Variation in Racial Disparities in Receipt of High-Dose Influenza Vaccine Among US Older Adults.

Silva J, Howe C, Jackson J, Riester M, Bardenheier B, Xu L J Racial Ethn Health Disparities. 2023; 11(3):1520-1529.

PMID: 37184814 PMC: 10184628. DOI: 10.1007/s40615-023-01628-z.


Assessing barriers to access and equity for COVID-19 vaccination in the US.

Kuehn M, LaMori J, DeMartino J, Mesa-Frias M, Doran J, Korrapati L BMC Public Health. 2022; 22(1):2263.

PMID: 36463172 PMC: 9719622. DOI: 10.1186/s12889-022-14636-1.


References
1.
Haq K, McElhaney J . Immunosenescence: Influenza vaccination and the elderly. Curr Opin Immunol. 2014; 29:38-42. DOI: 10.1016/j.coi.2014.03.008. View

2.
Czaja C, Miller L, Alden N, Wald H, Cummings C, Rolfes M . Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza-U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET). Open Forum Infect Dis. 2019; 6(7). PMC: 6602897. DOI: 10.1093/ofid/ofz225. View

3.
McElhaney J, Zhou X, Talbot H, Soethout E, Bleackley R, Granville D . The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine. 2012; 30(12):2060-7. PMC: 3345132. DOI: 10.1016/j.vaccine.2012.01.015. View

4.
Grohskopf L, Alyanak E, Broder K, Walter E, Fry A, Jernigan D . Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season. MMWR Recomm Rep. 2019; 68(3):1-21. PMC: 6713402. DOI: 10.15585/mmwr.rr6803a1. View

5.
DiazGranados C, Dunning A, Kimmel M, Kirby D, Treanor J, Collins A . Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014; 371(7):635-45. DOI: 10.1056/NEJMoa1315727. View